1 – 49 of 49
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Non-Motor Symptom Management : Insights into Adherence to Treatment Guidelines in Parkinson’s Disease Patients
(
- Contribution to journal › Article
-
Mark
Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson’s Disease
(
- Contribution to journal › Article
-
Mark
The AAV-α-Synuclein Model of Parkinson's Disease : An Update
2024) In Journal of Parkinson's Disease(
- Contribution to journal › Scientific review
-
Mark
Chronotropic Incompetence in Parkinson's Disease : A Possible Marker of Severe Disease Phenotype?
2024) In Journal of Parkinson's Disease(
- Contribution to journal › Article
- 2022
-
Mark
Human Embryonic Stem Cell-Derived Dopaminergic Grafts Alleviate L-DOPA Induced Dyskinesia
(
- Contribution to journal › Article
-
Mark
Cardiac Alpha-Synuclein Is Present in Alpha-Synucleinopathies
(
- Contribution to journal › Article
-
Mark
A Combined α-Synuclein/Fibril (SynFib) Model of Parkinson-Like Synucleinopathy Targeting the Nigrostriatal Dopamine System
(
- Contribution to journal › Scientific review
-
Mark
Insights on Genetic and Environmental Factors in Parkinson's Disease from a Regional Swedish Case-Control Cohort
(
- Contribution to journal › Article
- 2021
-
Mark
Dopamine Cell Therapy : From Cell Replacement to Circuitry Repair
(
- Contribution to journal › Scientific review
-
Mark
Decreased Risk of Parkinson's Disease After Rheumatoid Arthritis Diagnosis : A Nested Case-Control Study with Matched Cases and Controls
(
- Contribution to journal › Article
-
Mark
Grafts Derived from an α-Synuclein Triplication Patient Mediate Functional Recovery but Develop Disease-Associated Pathology in the 6-OHDA Model of Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Stem Derived Dopamine Neurons : Will They Replace DBS as the Leading Neurosurgical Treatment for Parkinson's Disease?
(
- Contribution to journal › Article
-
Mark
GDNF Therapy : Can We Make It Work?
(
- Contribution to journal › Article
-
Mark
Repairing the Parkinson Brain
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
DNAJB6b is Downregulated in Synucleinopathies
(
- Contribution to journal › Article
- 2020
-
Mark
BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia
(
- Contribution to journal › Article
-
Mark
Animal Models of Parkinson's Disease : Are They Useful or Not?
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Challenges to informed consent in first-in-human trials involving novel treatments: A case study of Parkinson’s disease
(
- Contribution to journal › Article
-
Mark
Factors Contributing to Perceived Walking Difficulties in People with Parkinson’s Disease
(
- Contribution to journal › Article
-
Mark
Olfactory Impairment in Parkinson's Disease Studied with Diffusion Tensor and Magnetization Transfer Imaging
(
- Contribution to journal › Article
- 2016
-
Mark
Associations between TOMM40 Poly-T Repeat Variants and Dementia in Cases with Parkinsonism.
(
- Contribution to journal › Article
-
Mark
Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016?
(
- Contribution to journal › Article
-
Mark
Variation in Recent Onset Parkinson's Disease : Implications for Prodromal Detection
(
- Contribution to journal › Article
- 2015
-
Mark
Intraindividual Variability of Nonmotor Fluctuations in Advanced Parkinson's Disease.
(
- Contribution to journal › Article
-
Mark
Concerns About Falling in Parkinson's Disease: Associations with Disabilities and Personal and Environmental Factors.
(
- Contribution to journal › Article
-
Mark
Barriers and Facilitators for Participation in People with Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Anticholinergic Load : Is there a Cognitive Cost in Early Parkinson's Disease?
(
- Contribution to journal › Article
-
Mark
Tracking Parkinson's : Study Design and Baseline Patient Data
(
- Contribution to journal › Article
- 2014
-
Mark
The Significance of Walking from the Perspective of People with Parkinson's Disease.
(
- Contribution to journal › Article
-
Mark
Is Exenatide the Next Big Thing in Parkinson's Disease?
(
- Contribution to journal › Article
-
Mark
Which patients with Parkinson's disease participate in clinical trials? : One centre's experiences with a new cell based therapy trial (TRANSEURO)
(
- Contribution to journal › Article
-
Mark
Mild cognitive impairment and Parkinson's disease - something to remember
(
- Contribution to journal › Article
-
Mark
Quality of life and mild cognitive impairment in early Parkinson's disease : does subtype matter?
(
- Contribution to journal › Article
- 2013
-
Mark
Bad News for Neuroprotective Therapies in PD?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
mTOR Inhibition Alleviates L-DOPA-Induced Dyskinesia in Parkinsonian Rats
(
- Contribution to journal › Article
-
Mark
Linked clinical trials - the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatments
(
- Contribution to journal › Article
-
Mark
Personality affects aspects of health-related quality of life in Parkinson's disease via psychological coping strategies
(
- Contribution to journal › Article
-
Mark
The relationship between abnormalities of saccadic and manual response times in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Perceptions of participation among people with Parkinson's disease.
(
- Contribution to journal › Published meeting abstract
-
Mark
Discriminant capacity of four Fear of Falling rating scales in people with Parkinson's disease.
(
- Contribution to journal › Published meeting abstract
-
Mark
Walking difficulties is the strongest contributing factor to fear of falling among people with mild Parkinson's disease.
(
- Contribution to journal › Published meeting abstract
-
Mark
The impact of physical environmental barriers on accessibility problems - very old people with self-reported Parkinson's disease versus controls.
(
- Contribution to journal › Published meeting abstract
-
Mark
Found in transcription : accurate Parkinson's disease classification in peripheral blood
(
- Contribution to journal › Article
- 2012
-
Mark
A Model of GDNF Gene Therapy in Mice with 6-Hydroxydopamine Lesions: Time Course of Neurorestorative Effects and ERK1/2 Activation
(
- Contribution to journal › Article
- 2011
-
Mark
Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Journal of Parkinson's Disease Introduction
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Measurement Properties of the SF-12 Health Survey in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Membrane Interaction of α-Synuclein in Different Aggregation States
(
- Contribution to journal › Article
-
Mark
Putaminal Upregulation of FosB/Delta FosB-Like Immunoreactivity in Parkinson's Disease Patients with Dyskinesia
(
- Contribution to journal › Article